🔬TimeTeller's Circadian Rhythm Test for Cancer Patients

Cancer patients get a circadian rhythm test to time treatments better

TimeTeller, a German startup, has developed a saliva test kit to help cancer patients understand their circadian rhythm, potentially reducing side effects and improving treatment outcomes. The test, led by a physicist-engineer and molecular biologist with a background in oncology and systems medicine, operates on two timelines: short-term and long-term. The short-term goal is to help patients better tolerate cancer treatments, while the long-term goal is to determine the optimal timing for treatments. TimeTeller has secured a partnership with Techniker Krankenkasse, one of Germany's largest health insurance providers, to offer the test to a subset of cancer patients. The company's broader ambitions include applications in metabolic diseases, neurodegenerative diseases, performance, and women's health.